Skip to main content
SpringerLink
Log in

Design of a new multiple-unit controlled-release formulation of metoprolol — Metoprolol CR

  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

A new controlled-release (CR) formulation of the β1-selective adrenoceptor antagonist metoprolol1 has been developed, aiming at an even 24-h pharmacological effect. In order to achieve this, using a once-daily dose, factors such as absorption characteristics, physicochemical properties, and technological aspects had to be considered. The new formulation, called metoprolol CR, is a disintegrating tablet consisting of several hundred coated pellets of metoprolol succinate, each pellet being its own CR delivery unit.

In vitro testing and in vivo studies in healthy volunteers show that the new CR formulation gives continuous delivery of metoprolol throughout the day, resulting in smooth plasma concentration profiles, without peaks and troughs. The release of the drug is independent of pH and other physiological variables, such as food intake, which do not seem to alter the biopharmaceutical properties of the formulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Johnsson G, Regårdh C-G, Sölvell L (1975) Combined pharmacokinetic and pharmacodynamic studies in man of the adrenergic β1-receptor antagonist metoprolol. Acta Pharmacol Toxicol (Copenh) 36 [Suppl 5]: 31–44

    Google Scholar 

  2. Harron DWG, Balnave K, Kinney CD, Wilson R, Russell CJ, Shanks RG (1981) Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol. Clin Pharmacol Ther 29: 295–302

    Google Scholar 

  3. Sandberg A, Blomqvist I, Jonsson UE, Lundborg P (1986) Controlled rate of drug delivery for once daily treatment with metoprolol. Acta Pharmacol Toxicol (Copenh) 59 [Suppl 5]: 85

    Google Scholar 

  4. Silas JH, Freestone S, Lennard MS, Ramsay LE (1985) Comparison of two slow-release formulations of metoprolol with conventional metoprolol and atenolol in hypertensive patients. Br J Clin Pharmacol 20: 387–391

    Google Scholar 

  5. Asplund J, Öhman P (1981) Metoprolol administered once daily in the treatment of hypertension. Ann Clin Res 13 [Suppl 30]: 30–36

    Google Scholar 

  6. Uusitalo AJ, Keyriläinen O (1979) Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective β-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris. Ann Clin Res 11: 199–204

    Google Scholar 

  7. Jonsson UE, Sandberg A (1983) Absorption study of metoprolol with positioned release capsule. In: Abstract book from Second International Conference on Drug Absorption 1983: Rate control in drug therapy. Edinburgh, p 68

  8. Godbillon J, Evard D, Vidon N, Duval M, Schoeller JP, Bernier JJ, Hirtz J (1985) Investigation of drug absorption from the gastrointestinal tract of man. III. Metoprolol in the colon. Br J Clin Pharmacol 19 [Suppl 2]: 113S-118S

    Google Scholar 

  9. Theeuwes F, Swanson DR, Guittard G, Ayer A, Khanna S (1985) Osmotic delivery systems for the β-adrenoceptor antagonists metoprolol and oxprenolol: design and evaluation of systems for once-daily administration. Br J Clin Pharmacol 19 [Suppl 2]: 69S–76S

    Google Scholar 

  10. Langenbucher F (1982) Numerical convolution/deconvolution as a tool for correlating in vitro with in vivo drug availability. Pharm Ind 44: 1166–1172

    Google Scholar 

  11. Melander A, Danielson K, Scherstén B, Wåhlin E (1977) Enhancement of the bioavailability of propranolol and metoprolol by food. Clin Pharmacol Ther 22: 108–112

    Google Scholar 

  12. McLean AJ, McNamara PJ, duSouich P, Gibaldi M, Lalka D (1978) Food, splanchnic blood flow, and bioavailability of drugs subject to first-pass metabolism. Clin Pharmacol Ther 24: 5–10

    Google Scholar 

  13. Karim A, Burns T, Wearley L, Streicher J, Palmer M (1985) Food-induced changes in theophylline absorption from controlled-release formulations. Part I. Substantial increased and decreased absorption with Uniphyl tablets and Theo-Dur sprinkle. Clin Pharmacol Ther 38: 77–83

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmaceutical Research and Development, AB Hässle, Mölndal, Sweden

    A. Sandberg, G. Ragnarsson, U. E. Jonsson & J. Sjögren

Authors
  1. A. Sandberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Ragnarsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. U. E. Jonsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Sjögren
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sandberg, A., Ragnarsson, G., Jonsson, U.E. et al. Design of a new multiple-unit controlled-release formulation of metoprolol — Metoprolol CR. Eur J Clin Pharmacol 33 (Suppl 1), S3–S7 (1988). https://doi.org/10.1007/BF00578405

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00578405

Key words

Search

Navigation